Synageva BioPharma Announces Closing of Public Offering and Exercise of Over …

… today announced the closing of a $90 million underwritten public offering of 3574266 shares of a common stock, including 466209 shares of common stock which were issued pursuant to the exercise of the underwriters' over-allotment option, …
See all stories on this topic »